Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety

Mesenchymal stromal cells (MSCs) are used as salvage therapy to treat steroid-refractory acute graft-versus-host disease (aGvHD). We studied the immunological response to MSC treatment in 16 aGvHD patients by assessing lymphocyte profiles and three proposed aGvHD serum markers during the MSC treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Keto, Joni, Kaartinen, Tanja, Salmenniemi, Urpu, Castrén, Johanna, Partanen, Jukka, Hänninen, Arno, Korhonen, Matti, Lähteenmäki, Kaarina, Itälä-Remes, Maija, Nystedt, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834657/
https://www.ncbi.nlm.nih.gov/pubmed/29516024
http://dx.doi.org/10.1016/j.omtm.2018.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834657/
https://www.ncbi.nlm.nih.gov/pubmed/29516024
http://dx.doi.org/10.1016/j.omtm.2018.02.001

Ejemplares similares